Our initial focus will address the huge clinical unmet need of patients with Type 1 Diabetes.
Provides long-term auto-regulation therapeutic solution without recharge or refill. Our device is made from material approved in other FDA approved medical devices, and has demonstrated small animal proof of concept.
Our technology solution
Our device will be loaded glucose responsive insulin secreting cells, and implanted under the skin. Once inside the device cells are protected from the immune system but still able to maintain nutrient exchange to respond to their environment.
Our ultra thin-film membranes (top), have been used to create our thin and flexible device (center left), and implanted in animals (center right) to demonstrate allo protection in vivo at 30, 60, 90 days (bottom).